Intuitive Surgical, Inc. $ISRG Stake Raised by Telligent Fund LP

Telligent Fund LP raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.1% during the 2nd quarter, HoldingsChannel reports. The fund owned 4,000 shares of the medical equipment provider’s stock after purchasing an additional 400 shares during the period. Intuitive Surgical accounts for approximately 2.0% of Telligent Fund LP’s portfolio, making the stock its 26th biggest holding. Telligent Fund LP’s holdings in Intuitive Surgical were worth $2,174,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the business. Aaron Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the period. J. W. Coons Advisors LLC lifted its position in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after buying an additional 20 shares in the last quarter. Exencial Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after buying an additional 20 shares during the period. Evergreen Capital Management LLC grew its holdings in shares of Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after acquiring an additional 20 shares in the last quarter. Finally, Rise Advisors LLC increased its stake in shares of Intuitive Surgical by 5.6% in the first quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after acquiring an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 116,164 shares of company stock valued at $61,916,172 in the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $564.64 on Thursday. The business’s 50-day simple moving average is $487.92 and its 200-day simple moving average is $503.76. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market cap of $202.41 billion, a price-to-earnings ratio of 74.69, a P/E/G ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the company earned $1.84 EPS. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research reports. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $599.00 to $600.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Hsbc Global Res upgraded Intuitive Surgical to a “strong-buy” rating in a report on Thursday, October 23rd. Wall Street Zen cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.